Lobe Sciences Ltd at Q1 Virtual Investor Summit Transcript
Good morning, everyone. I'd like to introduce Philip Young, CEO of Lobe Sciences. He will be presenting for 30 minutes and perhaps taking questions at the end of his presentation. Philip, take it away.
Thank you, Nelsa. And thanks for joining us and I look forward to some questions at the end. And thanks to the Investor Summit for putting the conference on. What I'd like to do is review where Lobe has been and where Lobe is headed to in 2022.
We've got really exciting plans this year for growing the company, taking the next steps to being really a fully integrated biotech company, developing therapeutics. But before we go there, I have to let you know that -- excuse me, that I'll be making some forward-looking statements. And that all of our filings are current on SEDAR and please feel free to read them for any clarifications.
So who's Lobe and what are we doing today? Well, we're a biotech company that's developing and delivering therapeutics to improve the human condition
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
